461 related articles for article (PubMed ID: 28124219)
1. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
[TBL] [Abstract][Full Text] [Related]
2. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
Sarina B; Mariotti J; Bramanti S; Morabito L; Crocchiolo R; Rimondo A; Tordato F; Pocaterra D; Casari E; De Philippis C; Carlo-Stella C; Santoro A; Castagna L
Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
[TBL] [Abstract][Full Text] [Related]
4. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
5. [The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation].
Zhang Y; Liu C; Liu QF; Sun J; Fan ZP; Xu D; Jiang QL
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2814-7. PubMed ID: 20137659
[TBL] [Abstract][Full Text] [Related]
6. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
Dvorak CC; Steinbach WJ; Brown JM; Agarwal R
Bone Marrow Transplant; 2005 Oct; 36(7):621-9. PubMed ID: 16044133
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting.
Busca A; Passera R; Maffini E; Festuccia M; Brunello L; Dellacasa CM; Aydin S; Frairia C; Manetta S; Butera S; Iovino G; Giaccone L; Sorror M; Storb R; De Rosa FG; Bruno B
Bone Marrow Transplant; 2018 Oct; 53(10):1304-1310. PubMed ID: 29654289
[TBL] [Abstract][Full Text] [Related]
8. Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish Pediatric Bone Marrow Transplantation Study Group.
Hazar V; Karasu GT; Uygun V; Öztürk G; Kiliç SÇ; Küpesiz A; Daloglu H; Aksoylar S; Atay D; Ince EÜ; Karakükçü M; Özbek N; Tayfun F; Kansoy S; Özyürek E; Akçay A; Gürsel O; Haskologlu S; Kaya Z; Yilmaz S; Tanyeli A; Yesilipek A
Med Mycol; 2019 Feb; 57(2):161-170. PubMed ID: 29608706
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
[TBL] [Abstract][Full Text] [Related]
10. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
Fukuda T; Boeckh M; Carter RA; Sandmaier BM; Maris MB; Maloney DG; Martin PJ; Storb RF; Marr KA
Blood; 2003 Aug; 102(3):827-33. PubMed ID: 12689933
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation.
Blennow O; Remberger M; Törlén J; Szakos A; Ljungman P; Mattsson J
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1684-1689. PubMed ID: 27311967
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
[TBL] [Abstract][Full Text] [Related]
13. Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation.
Christen D; Sohlbach K; Metzelder SK; Wollmer E; Hoeffkes HG; Naumann R; Burchardt A; Rummel M; Trenker C; Dohse M; Mack E; Klameth A; Mann C; Kostrewa P; Brendel C; Wündisch T; Neubauer A; Wilhelm C; Burchert A
Leuk Lymphoma; 2019 Aug; 60(8):2056-2061. PubMed ID: 30644334
[TBL] [Abstract][Full Text] [Related]
14. Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years.
Shi JM; Pei XY; Luo Y; Tan YM; Tie RX; He JS; Zheng WY; Zhang J; Cai Z; Lin MF; Huang H
J Zhejiang Univ Sci B; 2015 Sep; 16(9):796-804. PubMed ID: 26365122
[TBL] [Abstract][Full Text] [Related]
15. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
[TBL] [Abstract][Full Text] [Related]
16. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic SCT in patients with a history of invasive fungal infection.
Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
[TBL] [Abstract][Full Text] [Related]
18. [Invasive fungal infections after allogeneic hematopoietic stem cell transplantation and related risk factors].
Wang ZY; Jiang EL; Zhang P; Wang H; Bao YS; Wang M; Feng SZ; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):618-22. PubMed ID: 18549641
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
[TBL] [Abstract][Full Text] [Related]
20. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina.
Gomez SM; Caniza M; Fynn A; Vescina C; Ruiz CD; Iglesias D; Sosa F; Sung L
Transpl Infect Dis; 2018 Aug; 20(4):e12913. PubMed ID: 29679436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]